Cena Research Institute

Founded in 2014 and based in Houston, TX, Cena Research Institute (CRI) is a leader in clinical research, driven by a multidisciplinary team of MDs, PhDs, postgraduates, medical students, and undergraduates collaborating to advance medical science. CRI specializes in conducting both invasive and noninvasive clinical research, pharmaceutical trials, medical technology research, and R&D initiatives, with a steadfast commitment to innovation and excellence. At the core of our mission is a dedication to inclusivity in clinical trials, emphasizing participation from underrepresented groups in medicine. Our focus areas include underserved populations—such as women, the elderly, and minority communities—ensuring diverse voices contribute to and benefit from scientific advancements. CRI addresses underutilized therapies, including groundbreaking work in pharmaceuticals and medical technology, expanding access and application of these treatments. Understanding the importance of comprehensive healthcare, CRI prioritizes research on underrepresented illnesses, including rare diseases and genetic disorders, filling crucial gaps in medical knowledge and treatment options. Our commitment to diversity extends to fostering inclusive clinical trials that represent varied communities, age groups, and genders. With multilingual support in English, Spanish, Arabic, Vietnamese, and Hindi/Urdu, we bridge communication gaps, ensuring that participants from diverse backgrounds are heard and understood. At CRI, we believe that “We set the tone for research inclusivity,” underscoring our mission to redefine clinical research standards and champion inclusivity, equity, and innovation in every aspect of our work.